ReviewCurrent diabetes reports2013
Establishing consensus in the diagnosis of gestational diabetes following HAPO: where do we stand?
Review in Current diabetes reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Trends in gestational diabetes prevalence in China from 1990 to 2024: a systematic review and meta-analysis.Reviews in endocrine & metabolic disorders · 2025Pooled it
- Predictive Utility of Biochemical Markers for the Diagnosis and Prognosis of Gestational Diabetes Mellitus.International journal of molecular sciences · 2024Review
- MicroRNAs Associated with the Pathophysiological Mechanisms of Gestational Diabetes Mellitus: A Systematic Review for Building a Panel of miRNAs.Journal of personalized medicine · 2023Review
- Changed definition of disease and broader screening criteria had little impact on prevalence of gestational diabetes mellitus.Acta obstetricia et gynecologica Scandinavica · 2022Article
- Article
- MiRNAs in Gestational Diabetes Mellitus: Potential Mechanisms and Clinical Applications.Journal of diabetes research · 2021Review
- First-trimester fasting glycemia as a predictor of gestational diabetes (GDM) and adverse pregnancy outcomes.Acta diabetologica · 2020Article
- Metabolomics of Diabetes in Pregnancy.Current diabetes reports · 2017Review
- Diagnosing gestational diabetes mellitus: implications of recent changes in diagnostic criteria and role of glycated haemoglobin (HbA1c).Clinical medicine (London, England) · 2017Article
- Gestational Diabetes Testing, Narrative, and Medical Distrust.Journal of bioethical inquiry · 2017Article
- Early Pregnancy Biochemical Predictors of Gestational Diabetes Mellitus.Current diabetes reports · 2017Review
- Updated guidelines on screening for gestational diabetes.International journal of women's health · 2015Review
- Counterpoint: Establishing consensus in the diagnosis of GDM following the HAPO study.Current diabetes reports · 2014Review
- Shape information in repeated glucose curves during pregnancy provided significant physiological information for neonatal outcomes.PloS one · 2014Article
- Advancements and challenges in generating accurate animal models of gestational diabetes mellitus.American journal of physiology. Endocrinology and metabolism · 2013Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
New proposals for the diagnosis of gestational diabetes (GDM), promulgated by the International Association of Diabetes and Pregnancy Study Groups (IADPSG), will substantially increase the number of women diagnosed with GDM. This will have an enormous impact on healthcare resources, diverting attention away from genuinely high risk diabetic pregnancies. Randomized trials in 'mild' GDM indicate that the main effects of treatment are a 2 %-3 % reduction in birth weight, fewer 'big babies', and less shoulder dystocia. However, these studies used different diagnostic criteria, and women diagnosed by the broader IADPSG criteria may not derive the same modest benefit. Modeling indicates a very high cost per QALY, unless later development of type 2 diabetes can be prevented. Far from producing consensus, the IADPSG suggestion has thrown sharply into focus the need to assess critically the risks, costs and benefits of adopting criteria that may pathologize a large number of otherwise normal pregnancies.
Indexed as
Identifiers
23054748What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.